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Abstract
Neurofibrillary tangles (NFTs) of tau are one of the defining hallmarks of Alzheimer’s disease (AD), and are closely
associated with neuronal degeneration. Although it has been suggested that calcium dysregulation is important to AD
pathogenesis, few studies have probed the link between calcium homeostasis, synapse loss and pathological
changes in tau. Here we test the hypothesis that pathological changes in tau are associated with changes in calcium
by utilizing in vivo calcium imaging in adult rTg4510 mice that exhibit severe tau pathology due to over-expression of
human mutant P301L tau. We observe prominent dendritic spine loss without disruptions in calcium homeostasis,
indicating that tangles do not disrupt this fundamental feature of neuronal health, and that tau likely induces spine
loss in a calcium-independent manner.
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Introduction
The Alzheimer Disease (AD) brain accumulates intracellular
neurofibrillary tangles, composed primarily of the microtubule
associated protein tau and extracellular amyloid-β plaques. The
AD brain is also characterized by synaptic and neuronal loss,
which more closely correlate with cognitive decline in AD than
the histological hallmarks of the disease [1-5]. Calcium
dysregulation has been proposed to subserve synapse loss
and is thought to be one of the earliest events in AD [6-10]. It is
well known that mutations in genes that influence amyloid beta
processing occur in familial variants of AD, and much emphasis
has thus been placed in understanding the toxic consequences
of Aβ, which has been linked to disruptions in calcium
homeostasis in several models [11,12]. However, the role of
calcium interactions in tau related AD pathogenesis and, in
particular, in synapse loss has not been clearly delineated.
Calcium is a tightly regulated signaling molecule imperative
to normal neuronal function. At the synapse, calcium is critical
for inter-neuronal signaling, which underlies the processes
involved in learning and memory [13,14]. At non-synaptic sites,
calcium is critical for intra-neuronal signaling cascades, which
when altered can lead to initiation of apoptotic cell death.
Pathological increases in intracellular calcium levels have been
demonstrated to increase levels of tau hyperphosphorylation
[15,16], and tau accumulation in dendrites has been associated
with local calcium elevations after application of Aβ to primary
neurons in culture [12], leading to the supposition that tau
alterations are downstream of calcium elevations. There is also
some evidence for the inverse relationship, i.e. that
pathological changes in tau are upstream of calcium
dyshomeostasis. In cells that are exposed to extracellular tau
or over-express tau, hyperphosphorylation, misfolding and
mislocalization of tau is accompanied by disruptions in
mitochondrial calcium buffering and cellular calcium
homeostasis [8,12,17,18]. However, there are no data to our
knowledge that test whether tau alterations are upstream of
calcium dysregulation in the intact brain.
Traditionally, the tau protein has been known as a
predominantly axonal protein, where it stabilizes microtubules
and plays an important role in neuronal transport and function
[19,20]. Recent studies indicate that tau may have additional
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functions beyond the axon, in dendrites and at post-synaptic
sites [21-24]. These recent studies show that 1) tau plays a
physiological role at dendritic spines [24], 2) tau and Aβ both
cause synapse loss independently [25,26], and 3) elevated
calcium levels are associated with Aβ–induced synapse loss
[27,28], which leads to the question of whether the molecular
cascade leading to tau induced synapse loss also involves
increased calcium levels in dendrites and dendritic spines.
In this study, we used in vivo multiphoton imaging of yellow
cameleon 3.6 (YC3.6), a ratiometric FRET based calcium
indicator encoded and delivered by an adeno-associated virus
(YC3.6AAV2) [27,29] to visualize intracellular calcium
concentration in the brain of living adult mice that over-express
human mutant P301L tau (rTg4510). At 8-9 months of age,
these mice are beginning to lose neurons and to accumulate
neurofibrillary tangles in the neocortex [30,31]. Further, P301L
tau expressing neurons at this age have been shown to have
either “atrophic” or “intact” morphologies with atrophic neurons
demonstrating dendritic spine loss and loss of dendritic
branches [32], indicating that this is a time when synapse loss
is actively occurring. Here we demonstrate that 8-9 month old
rTg4510 mice exhibit significant loss of dendritic spines but
maintain baseline calcium levels in dendrites and dendritic
spines despite accumulation of tau pathology. These data
indicate that pathological changes in tau cause synapse loss in
a calcium-independent manner, suggesting that pathological
changes in tau may be downstream of both Aβ and calcium
dysregulation in synapse loss in AD.
Materials and Methods
Animals
In this study, we used the rTg4510 mouse model of
regulatable P301L human mutant tau over-expression. Mice
were generated as previously described with a responder
transgene containing a tetracycline-operon-responsive element
(TRE) upstream of cDNA of full length, four-repeat (0N4R),
P301L human tau and an activator transgene containing a tet-
off open reading frame downstream of calcium calmodulin
kinase II promoter elements [30,31,33]. When both activator
and responder transgene are present, this bigenic model
results in over-expression of human P301L tau limited to
forebrain structures. Littermate animals containing only the
activator transgene, which therefore do not express human
mutant tau were used as controls. Animals were aged to 8-9
months before experiments began (n=9 rTg4510 and 6
controls). Animal experiments were conducted in accordance
with NIH and Massachusetts General Hospital policies and
were approved by the Massachusetts General Hospital
Subcommittee on Research Animal Care.
Yellow cameleon 3.6 AAV2
For in vivo calcium imaging, adeno-associated virus (AAV2)
encoding the ratiometric calcium indicator yellow cameleon 3.6
(YC3.6) under the CBA promoter (YC3.6AAV2), was
intracortically injected into rTg4510 and control mice as
described previously [27,29]. The YC3.6AAV2 construct
contains a fluorescence resonance energy transfer (FRET)
based calcium indicator in which calcium calmodulin, a calcium
binding peptide, is flanked by cyan and yellow fluorescent
proteins (CFP and YFP respectively). Increases in calcium
binding alter the conformation of the indicator, decrease the
spatial distance between CFP and YFP, and increase FRET
efficiency, resulting in an increase in the ratio (R) of YFP/CFP
fluorescence. These ratios can be converted to calcium
concentrations after all data have been collected using the
equation [Ca2+]=Kd*((R-Rmin)/(Rmax-R))^(1/Hill) where Kd=277,
Hill=1.1, R=ratio, Rmin=minimum ratio=1.36, Rmax=maximum
ratio=2.48. Minimum and maximum ratios were defined as the
median of the lowest 5% and highest 5% of the YC ratios for
control animals. The viral titer was 5.0 x 1012.
Animal surgeries
Intracortical injections and cranial window implantations were
performed as previously described [27,34-36]. For intracortical
injections, mice were anaesthetized with ketamine/xylazine
(100 mg/kg, 10 mg/kg i.p.) and placed in a stereotax. Skin on
the top of the head was sterilized, local anesthetic injected and
a 2-3 mm incision made along the midline between the ears.
Using a high-speed drill, 2 burr holes were drilled in the skull,
1.5 mm lateral to bregma bilaterally, 0.5 mm caudal on the left
and 1.5 mm caudal on the right. 1.5 μL of YC3.6AAV2 was
injected at a rate of 0.25 μL/min and at a depth of 0.8-1.2 mm
into somatosensory cortex. Following one injection in each burr
hole, the scalp was sutured and the mouse allowed to recover
from anesthesia.
Following a three to four week incubation period to allow for
YC3.6 expression, mice were anaesthetized with isoflurane
and secured in a stereotax. The skin on the top of the head
was sterilized, a local anesthetic injected, and a circle of skin
covering the top of the head removed. A high-speed drill was
used to make a 6 mm circular craniotomy centered over both
injection sites. The brain was rinsed with PBS and an 8 mm
sterilized glass coverslip placed over the exposed brain and
glued to the skull with a Krazy Glue-dental cement mixture.
Mice were given three weeks recovery to prevent any calcium
artifacts due to swelling resultant from surgery.
Multiphoton in-vivo imaging
In vivo multiphoton images of YC3.6-filled neuronal
processes and dendritic spines were obtained as described
previously [27]. In short, mice were anaesthetized with
isoflurane and placed in a stereotax within the stage of an
Olympus BX61WI upright microscope with Olympus Fluoview
1000MPE, pre-chirp optics and fast AOM. A low melting point
wax restraining ring was applied to the periphery of the
coverslip and filled with distilled water to provide a well for the
Olympus 20x 0.95 NA water immersion objective. A MaiTai
titanium/sapphire laser (Spectra-Physics, Fremont CA)
generated two-photon fluorescence at an excitation wavelength
of 860 nm (laser power < 50 mW). Emitted light in the range of
380-480 nm (CFP) and 500-540 nm (YFP) was collected by
photomultiplier tube detectors (Hamamatsu, Ichinocho, Japan).
For dendrite analysis, image stacks were recorded at 0.8-1 μm
z-step size, 50-80x magnification, 512x512 px, and a scan rate
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of 4-8 μs/pixel. Image stacks for spine analysis were collected
at higher magnification (80-100x) and a step size of 0.8 μm.
Image analysis
Images were viewed and processed with ImageJ (National
Institutes of Health open software) and analyzed without
knowledge of condition. A custom-made macro was used to
generate a merged CFP-YFP image and a background
subtracted ratiometric image (R = (YFP - Background)/(CFP -
Background). Regions of interest (dendrites and dendritic
spines) were selected from ~10 volumes per animal in the
CFP-YFP merged image and applied to the ratiometric image
and measured to obtain YFP/CFP ratios (YC ratios).
Translation of ratio values to calcium concentrations occurred
only after statistical analysis.
Spine density was analyzed using NeuronStudio (Mt Sinai
School of Medicine, Computational Neurobiology and Imaging
Center) in combination with ImageJ. YC3.6-filled neurites >20
μm in length with at least three spines were selected for
analysis. Approximately 5-10 dendrites were selected for each
animal. Image stacks were opened in NeuronStudio and a
median blur filter run. The dendrite segment and spines were
selected semi-automatically and confirmed by comparison to
the 3D stack open in ImageJ in order to ensure that spines
counted connected to the dendritic shaft. Dendritic spine
density was calculated as spines per micrometer along the
dendritic shaft and compared to the calcium ratio of that parent
dendrite.
Statistical analyses
Normality of datasets was assessed with Shapiro-Wilks
tests. To determine whether calcium levels were significantly
elevated in rTg4510 brains, YC ratios of rTg4510 and control
mice were compared applying a mixed effects logistic
regression model. This model takes into account correlation
among dendrites and dendritic spines within mice by including
random effects for mice. Calcium overload thresholds were
determined for dendrites (Thrdend= 2.14) and dendritic spines
(Thrspine= 2.24) individually and set as the 95th percentile of the
respective YC ratios in control animals. Dendritic spine density
was analyzed by taking the mean dendritic spine density for
each animal and comparing the means of the rTg4510 and
control groups with student’s t-tests. To determine the
correlations between calcium concentration and spine density,
all dendrites used in the dendritic spine quantification were
analyzed with linear regression analysis and spearman’s rho
correlation analysis in JMP software.
Results
Calcium levels in dendrites and dendritic spines of
rTg4510 mice are not significantly different from
control
Using in vivo multi-photon imaging of the ratiometric calcium
indicator yellow cameleon (YC3.6) we quantified the resting
calcium levels in neuronal processes of living 8-month old
rTg4510 and control mouse brains. rTg4510 mice express
human P301L tau in most cortical neurons (under the control of
a tetracycline responsive element that is driven by a tet-off
open reading frame downstream of CamKIIα promoter
elements [30,37]) and at this age exhibit abnormal
accumulation of tau in the soma of a subset of neurons (Figure
S1). Injected YC3.6 fills cells, including dendrites, and dendritic
spines (Figure 1). It has previously been demonstrated that
changes in the YFP/CFP fluorescence ratio of the FRET-based
YC3.6 can be utilized as a reliable readout to monitor
intracellular calcium levels in the normal physiological range of
neuronal calcium concentrations [27]. Analysis of 4655
dendrites across 15 mice (rTg4510 n=9, control n=6)
demonstrated a maintenance of baseline calcium levels in
rTg4510 mice, expressing high amounts of human P301L tau
in the brain, when compared to control animals, with YC ratios
of 1.69±0.27 (mean±SD) in control dendrites and 1.66±0.24 in
rTg4510 dendrites, which translate into calcium concentrations
of 125.3±101.00 nM and 111.0±86.00 nM respectively (Figure
2A, B, D). In plaque-bearing APP/PS1 mice, 20% of neurites
demonstrated calcium overload [27]. To determine whether a
similar subpopulation of neurites exhibit elevated calcium
concentrations in rTg4510 mice, we identified the percentage
of dendrites exceeding the YC ratio value for the 95th percentile
for control mice. Applying a mixed effects logistic regression
model (Materials and Methods), no effect of tau overexpression
on the number of dendrites and dendritic spines with
overloaded calcium was detected (p>0.05). Similar to the data
from dendrites, the average YC ratios and calcium
concentrations in dendritic spines of rTg4510 (YC ratio
1.76±0.63, calcium 162.3±266.02 nM, n=1158 spines) were the
same as in control mice and demonstrated no effect of tau
over-expression on the number of spines exhibiting calcium
overload (YC ratio 1.76±0.33, calcium 162.3±139.34 nM,
Figure 2A, C, E).
Spine loss in rTg4510 mice independent of calcium
changes
Studies of tau over-expressing neurons in culture have linked
dendritic spine loss, the leading correlate to cognitive decline in
AD [1,2,20], to alterations in calcium handling and
mitochondrial mislocalization [12]. In addition, studies of Aβ
toxicity have suggested that calcium dyshomeostasis precedes
and leads to subsequent spine loss [8,9,14,16,38-42]. To
determine whether calcium concentrations in the rTg4510 mice
correlated with dendritic spine loss, spine density was
calculated in rTg4510 and control mice and matched with the
YC ratio of the parent dendrite in a subset of the dendrites
imaged. At 8-9 months of age, with expression of human
mutant P301L tau and tangles and neuronal loss in the
somatosensory cortex, rTg4510 dendrites showed a nearly
30% decrease in spine density (p=0.003) as shown in Figure 3.
This dramatic decrease in spine density in the rTg4510 brain
did not correlate with the YC ratio of the parent dendrite
(R2=0.197, multivariate pairwise correlation p=0.08, Figure 3),
suggesting that tau induced synapse loss is not associated with
sustained elevated calcium levels. We cannot exclude the
possibility that YC ratios and spine density did at some point
correlate, prior to such dramatic progression of pathology.
Normal Calcium Homeostasis in rTg4510 Brain
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Discussion
Many studies have demonstrated that alterations in APP
processing and Aβ can induce calcium dysregulation and have
established a strong link between increased calcium levels and
dendritic spine loss [8,9,14,27,39,41,43,44]. However, the
relationship between pathological changes in tau and calcium
homeostasis [45,46] has rarely been addressed. Here we
tested the hypothesis that the over-expression of human
mutant P301L tau, which leads to tau deposition and severe
neuronal loss in rTg4510 mice, alters calcium homeostasis and
causes synapse loss. At 8-9 months of age these mice have
extensive tau phosphorylation, neurofibrillary tangle formation,
neuronal loss in the neocortex [31]. As demonstrated both in
this study and previously, there is also substantial loss of
dendritic spines on cortical pyramidal neurons at this age
[25,47], but whether this is mediated by changes in intracellular
calcium concentrations had not previously been studied.
In general, tau mediated toxicity is thought to be primarily
resultant from disruptions of microtubule-dependent neuronal
transport processes, particularly in the anterograde direction,
proving especially disruptive to mitochondrial distribution
[48-51]. Pathological changes in tau, such as
hyperphosphorylation, mislocalization and misfolding are
known to have impair mitochondrial distribution and function
[52-54]. In cultured neurons, Aβ causes increased calcium
levels and dendritic spine loss concomitant with dendritic
accumulation of tau and disrupted mitochondrial distribution
[12]; however, whether aberrant accumulation of tau and
mitochondrial distribution deficits are “upstream” or
“downstream” of increased calcium was previously unknown.
Here we demonstrate in a mouse model of tauopathy that in
the absence of Aβ pathology, overexpression of P301L mutant
tau causes distinct dendritic spine loss but no detectable
increase in calcium concentrations in dendrites or dendritic
spines. From this study and previous data examining
mitochondrial distribution, we propose that the synaptic loss
induced by tau may be due to impaired axonal transport of
important synaptic cargoes including mitochondria, but that this
does not require increased calcium concentrations in dendrites.
Our data provide the first in vivo exploration of the
relationship between pathological changes in tau and calcium
homeostasis. We demonstrate that pathological changes in tau
are sufficient to cause synapse loss without detectable
alterations in resting calcium, which suggest different
mechanisms of synaptic toxicity of tau and of Aβ.
Figure 1.  Yellow cameleon imaging in rTg4510 and control mice.  In vivo multiphoton imaging of somatosensory cortex
neurons expressing the ratiometric calcium indicator YC3.6 (A) demonstrates that the indicator fills both dendrites (B, blue arrow
heads) and dendritic spines (B, yellow arrow heads). Calcium concentration images from control (C) and rTg4510 (D) mice were
calculated from YC ratio (YFP/CFP) images and color-coded according to the color gradient shown in the middle. Scale bars (B, C,
D) represent 10 μm.
doi: 10.1371/journal.pone.0080834.g001
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Figure 2.  Calcium concentrations in dendrites and spines are not disrupted by tau over-expression.  Average YC ratios
(YFP/CFP) and calcium concentrations recorded from dendrites and dendritic spines in control and rTg4510 mice (A). Distributions
of YC ratios in dendrites and dendritic spines from control (B, C) and rTg4510 mice (E, F) show no significant difference between
control and rTg4510 mice. The dashed vertical lines indicate calcium overload thresholds at the 95th percentile of the control mice
data, determined for dendrites and spines separately. Data are shown as mean ± standard deviation.
doi: 10.1371/journal.pone.0080834.g002
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Figure 3.  Spine loss in rTg4510 mice is independent of calcium dysregulation.  High-resolution in vivo images of dendrites
and spines from control (A) and rTg4510 (B) show substantial loss of spines in rTg4510 mice. For better visualization, the image
background was removed and the contrast adjusted. Analysis of dendritic spine densities was performed on raw images. The
average dendritic spine density (C) was significantly decreased in rTg4510 mice when compared to controls (*, p < 0.05). Spine
density in rTg4510 mice did not significantly correlate with YC ratios in the parental dendrite (D). Scale bars (A, B) represent 5 μm.
doi: 10.1371/journal.pone.0080834.g003
Normal Calcium Homeostasis in rTg4510 Brain
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Supporting Information
Methods S1.  Detail Western blot protocols and
immunofluorescence labeling of brain sections used in
Figure S1.
(DOCX)
Figure S1.  Expression of human P301L tau in rTg4510
cortex. Western Blot analysis of cortical brain extracts from 8-
month old mice shows substantial amounts of human tau,
detected by the human tau specific antibody HT7, in rTg4510
but not in control mice (A). Human tau immunolabeling in
paraformaldehyde fixed coronal sections of somatosensory
cortex, this time using human tau specific antibody Tau13 (B),
verifies strong cortical expression of human P301L tau in 9-
month old rTg4510 mice. Scale bars (B) represent 50 μm.
(TIFF)
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